Heron Therapeutics (HRTX) FCF Margin Growth (3y) (2020 - 2026)
Heron Therapeutics (HRTX) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
7,927.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
7,927.00 |
| Dec 31, 2025 |
10,375.00 |
| Sep 30, 2025 |
14,322.00 |
| Jun 30, 2025 |
7,408.00 |
| Mar 31, 2025 |
16,869.00 |
| Dec 31, 2024 |
19,055.00 |
| Sep 30, 2024 |
24,442.00 |
| Jun 30, 2024 |
26,930.00 |
| Mar 31, 2024 |
18,598.00 |
| Dec 31, 2023 |
27,360.00 |
| Sep 30, 2023 |
18,171.00 |
| Jun 30, 2023 |
16,922.00 |
| Mar 31, 2023 |
5,640.00 |
| Dec 31, 2022 |
-3,836.00 |
| Sep 30, 2022 |
-8,244.00 |
| Jun 30, 2022 |
-3,492.00 |
| Mar 31, 2022 |
-2,988.00 |
| Dec 31, 2021 |
-9,286.00 |
| Sep 30, 2021 |
-3,666.00 |
| Jun 30, 2021 |
7,714.00 |
